Deseret Mutual Benefit Administrators increased its stake in shares of Accenture plc (NYSE:ACN – Free Report) by 3.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,435 shares of the information technology services provider’s stock after purchasing an additional 72 shares during the quarter. Deseret Mutual Benefit Administrators’ holdings in Accenture were worth $857,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Swedbank AB boosted its stake in Accenture by 16.6% in the third quarter. Swedbank AB now owns 2,551,679 shares of the information technology services provider’s stock valued at $901,967,000 after acquiring an additional 363,401 shares in the last quarter. McAdam LLC boosted its position in shares of Accenture by 8.5% in the 3rd quarter. McAdam LLC now owns 1,248 shares of the information technology services provider’s stock worth $441,000 after purchasing an additional 98 shares in the last quarter. International Assets Investment Management LLC grew its stake in Accenture by 37,788.5% during the 3rd quarter. International Assets Investment Management LLC now owns 510,358 shares of the information technology services provider’s stock worth $180,401,000 after buying an additional 509,011 shares during the last quarter. Beese Fulmer Investment Management Inc. acquired a new position in Accenture during the 3rd quarter valued at about $218,000. Finally, Assenagon Asset Management S.A. boosted its holdings in Accenture by 4.7% in the third quarter. Assenagon Asset Management S.A. now owns 25,853 shares of the information technology services provider’s stock worth $9,139,000 after acquiring an additional 1,160 shares in the last quarter. Hedge funds and other institutional investors own 75.14% of the company’s stock.
Insider Buying and Selling at Accenture
In other Accenture news, CFO Angie Y. Park sold 685 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was sold at an average price of $354.38, for a total transaction of $242,750.30. Following the completion of the transaction, the chief financial officer now owns 8,674 shares of the company’s stock, valued at $3,073,892.12. This represents a 7.32 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Angela Beatty sold 375 shares of Accenture stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $358.50, for a total value of $134,437.50. Following the completion of the sale, the insider now directly owns 5,149 shares in the company, valued at $1,845,916.50. This represents a 6.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 22,280 shares of company stock valued at $8,316,190 over the last ninety days. Corporate insiders own 0.02% of the company’s stock.
Accenture Price Performance
Accenture (NYSE:ACN – Get Free Report) last posted its quarterly earnings data on Thursday, December 19th. The information technology services provider reported $3.59 EPS for the quarter, beating analysts’ consensus estimates of $3.43 by $0.16. Accenture had a return on equity of 26.91% and a net margin of 11.41%. The business had revenue of $17.69 billion during the quarter, compared to analysts’ expectations of $17.15 billion. During the same period in the previous year, the business earned $3.27 earnings per share. The business’s revenue was up 9.0% compared to the same quarter last year. As a group, equities analysts expect that Accenture plc will post 12.73 EPS for the current fiscal year.
Analysts Set New Price Targets
Several equities analysts have recently issued reports on the stock. StockNews.com upgraded shares of Accenture from a “hold” rating to a “buy” rating in a report on Monday, January 13th. Wolfe Research upgraded shares of Accenture from a “peer perform” rating to an “outperform” rating and set a $425.00 price target on the stock in a research note on Wednesday, January 8th. The Goldman Sachs Group upgraded shares of Accenture from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $370.00 to $420.00 in a research note on Friday, December 6th. BMO Capital Markets upped their target price on Accenture from $390.00 to $425.00 and gave the company a “market perform” rating in a research report on Friday, December 20th. Finally, Piper Sandler boosted their price target on Accenture from $422.00 to $429.00 and gave the company an “overweight” rating in a research note on Thursday, December 19th. Eight investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $387.22.
View Our Latest Stock Report on ACN
Accenture Company Profile
Accenture plc, a professional services company, provides strategy and consulting, industry X, song, and technology and operation services worldwide. The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data management; intelligent automation comprising robotic process automation, natural language processing, and virtual agents; and application management services, as well as software engineering services; strategy and consulting services; data and analytics strategy, data discovery and augmentation, data management and beyond, data democratization, and industrialized solutions comprising turnkey analytics and artificial intelligence (AI) solutions; metaverse; and sustainability services.
Featured Stories
- Five stocks we like better than Accenture
- The How And Why of Investing in Oil Stocks
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- 3 Ways To Invest In Coffee, Other Than Drinking It
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Accenture Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accenture and related companies with MarketBeat.com's FREE daily email newsletter.